Description

Rezonativ (anti-d human immunoglobulin) solution for injections 625 IU/ml. 1 ml. ampoule №1

Ingredients

Rezonativ contains anti-d human immunoglobulin as the active ingredient.

Dosage

The recommended dosage of Rezonativ is determined by a healthcare professional based on the patient’s condition and needs.

Indications

Rezonativ is indicated for the prevention of hemolytic disease of the newborn (HDN) in Rh D-negative pregnant women.

Contraindications

Do not use Rezonativ if you have a known hypersensitivity to human immunoglobulins.

Directions

Rezonativ is administered via intramuscular injection. Follow the instructions provided by your healthcare provider.

Scientific Evidence

Studies have shown that anti-D immunoglobulin is highly effective in preventing sensitization of Rh D-negative individuals to Rh D-positive red blood cells, thereby reducing the risk of HDN.

Clinical trials have demonstrated the safety and efficacy of Rezonativ in preventing Rh D alloimmunization in pregnant women.

Additional Information

It is important to note that Rezonativ should only be administered under the supervision of a healthcare professional to ensure proper dosage and monitoring for any adverse reactions.

Consult your doctor for more information on the use of Rezonativ and its potential benefits for you or your baby.